MedTrace Logo

Lymphoma in the Orbit

NCT01302912 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-11-04

No results posted yet for this study

Summary

Imaging techniques have considerably improved over the last decades and ocular adnexal lymphomas (OALs) nowadays can be detected. As major advances in immunophenotyping and molecular diagnostics in histology have been achieved offering an accurate diagnosis, the investigators would like to introduce that surgical biopsy of an orbital lymphoma becomes crucial for the possibility of a correct diagnosis and proper treatment. As radiotherapy accomplished great preciseness as well and OALs respond excellently to radiation, this therapy should be the treatment of choice in local defined lymphomas instead of blind treatment with steroids. Radiation results in great local control rates of 85% to 100%

* Trial with surgical intervention

Conditions

  • Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

Interventions

PROCEDURE

Lymphoma-Biopsy

Patients after biopsy of orbital lymphoma

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Karla Chaloupka, MD · University Hospital Zurich, Ophtalmic Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Completion
2012-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302912 on ClinicalTrials.gov